ERGOLOID MESYLATES Drug Patent Profile
✉ Email this page to a colleague
When do Ergoloid Mesylates patents expire, and when can generic versions of Ergoloid Mesylates launch?
Ergoloid Mesylates is a drug marketed by Mutual Pharm, Sun Pharm Industries, Watson Labs, Kv Pharm, Lederle, Superpharm, and Vangard. and is included in twenty NDAs.
The generic ingredient in ERGOLOID MESYLATES is ergoloid mesylates. There are four drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the ergoloid mesylates profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Ergoloid Mesylates
A generic version of ERGOLOID MESYLATES was approved as ergoloid mesylates by SUN PHARM INDUSTRIES on October 31st, 1991.
Summary for ERGOLOID MESYLATES
US Patents: | 0 |
Applicants: | 7 |
NDAs: | 20 |
Finished Product Suppliers / Packagers: | 1 |
Clinical Trials: | 2 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price information for ERGOLOID MESYLATES |
DailyMed Link: | ERGOLOID MESYLATES at DailyMed |
Recent Clinical Trials for ERGOLOID MESYLATES
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Elizabeth Berry-Kravis | Phase 2 |
Sinphar Pharmaceutical Co., Ltd | Phase 2 |